SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-045020
Filing Date
2024-05-20
Accepted
2024-05-20 12:09:38
Documents
40
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0206516-10q_actavia.htm   iXBRL 10-Q 332651
2 CERTIFICATION ea020651601ex31-1_actavia.htm EX-31.1 9834
3 CERTIFICATION ea020651601ex32-1_actavia.htm EX-32.1 3331
  Complete submission text file 0001213900-24-045020.txt   2050976

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rasp-20240331.xsd EX-101.SCH 25491
5 XBRL CALCULATION FILE rasp-20240331_cal.xml EX-101.CAL 17861
6 XBRL DEFINITION FILE rasp-20240331_def.xml EX-101.DEF 109373
7 XBRL LABEL FILE rasp-20240331_lab.xml EX-101.LAB 216039
8 XBRL PRESENTATION FILE rasp-20240331_pre.xml EX-101.PRE 115237
44 EXTRACTED XBRL INSTANCE DOCUMENT ea0206516-10q_actavia_htm.xml XML 143381
Mailing Address 5 PENN PLAZA, 19TH FLOOR, #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR, #1954 NEW YORK NY 10001 646-396-4087
ACTAVIA LIFE SCIENCES, INC. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191083 | Film No.: 24963071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)